文献速递血栓与止血

血小板减少与COVID-19患者死亡风险的关联

Thrombocytopenia and its association with mortality in patients with COVID-19.
PubMed 文献 · J Thromb Haemost · 2020-05-04

该回顾性研究纳入武汉金银潭医院1476例连续COVID-19患者,分析住院期间最低血小板计数与院内死亡的关系。结果显示20.7%患者发生血小板减少,最低血小板计数越低,院内死亡率越高,且与死亡风险增加独立相关。

要点

  • COVID-19患者血小板减少发生率20.7%,与院内死亡风险增加相关。
  • 最低血小板计数(0,50]×10^9/L组院内死亡率达92.1%。
  • 血小板计数越低,死亡风险越高,呈剂量依赖性关联。

核心结论

  • COVID-19患者中血小板减少常见,且与院内死亡风险增加相关。
  • 最低血小板计数越低,院内死亡率越高。

研究设计与样本

  • 回顾性收集武汉金银潭医院1476例连续COVID-19患者住院期间最低血小板计数。

主要发现

  • 238例(16.1%)患者死亡,306例(20.7%)发生血小板减少。
  • 死亡患者较存活者年龄更大、更易发生血小板减少且最低血小板计数更低。
  • 四组院内死亡率分别为92.1%、61.2%、17.5%和4.7%。

临床怎么用

  • 监测COVID-19患者血小板计数有助于识别院内死亡高风险人群。
  • 血小板计数越低提示预后越差,需加强临床关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes novel coronavirus disease 2019 (COVID-19), is spreading rapidly around the world. Thrombocytopenia in patients with COVID-19 has not been fully studied. OBJECTIVE: To describe thrombocytopenia in patients with COVID-19. METHODS: For each of 1476 consecutive patients with COVID-19 from Jinyintan Hospital, Wuhan, China, nadir platelet count during hospitalization was retrospectively collected and categorized into (0, 50], (50, 100], (100-150], or (150-) groups after taking the unit (×109 /L) away from the report of nadir platelet count. Nadir platelet counts and in-hospital mortality were analyzed. RESULTS: Among all patients, 238 (16.1%) patients were deceased and 306 (20.7%) had thrombocytopenia. Compared with survivors, non-survivors were older, were more likely to have thrombocytopenia, and had lower nadir platelet counts. The in-hospital mortality was 92.1%, 61.2%, 17.5%, and 4.7% for (0, 50], (50, 100], (100-150], and (150-) groups, respectively. With (150-) as the reference, nadir platelet counts of (100-150], (50, 100], and (0, 50] groups had a relative risk of 3.42 (95% confidence interval [CI] 2.36-4.96), 9.99 (95% CI 7.16-13.94), and 13.68 (95% CI 9.89-18.92), respectively. CONCLUSIONS: Thrombocytopenia is common in patients with COVID-19, and it is associated with increased risk of in-hospital mortality. The lower the platelet count, the higher the mortality becomes.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020. PMID: 32302435. doi:10.1111/jth.14848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。